Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT01577394
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 65 and over
* Patients with a diagnosis of probable DLB or AD according to the Consortium on DLB criteria (McKeith et al 2005) for Lewy bodies dementia and according to DSM IV and NINCDS- ADRDA criteria for AD or patients in whom there is diagnostic uncertainty between DLB and AD
* No major sensory deficits
* MMSE \> 20
* Having signed an informed consent form
Exclusion Criteria:
* Parkinson syndrome progressing for more than one year regarding cognitive impairment
* Use of AchEIs medication
* Taking or having taken anti Parkinson drugs
* Neuroleptic drugs over the previous three months
* Contraindication for lumbar puncture (i.e. anticoagulant agents)
* Patients with Geriatric Depression Scale (GDS) \> 10
* Taking medication that could impact dopamine transporter's measurement
* Contraindication for MRI examination
* Diseases involving the short-term survival (shorter than one year)
* Not fluent in French
* Major sensory deficits that could interfere with cognitive assessment (visual and auditory)
* Being under guardianship
* Absence of caregiver/informant to sign informed consent form
* Non health insurance affiliation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT01577394
Study Brief:
Protocol Section:
NCT01577394